Literature DB >> 11918456

Elevated serum cancer antigen 125 levels in advanced abdominal tuberculosis.

V Thakur1, U Mukherjee, K Kumar.   

Abstract

A 48-yr-old female presented with a 1-yr history of pain in the hypochondrium and epigastrium. All routine investigations and computed tomography (CT) of the abdomen were done. CT findings revealed a well-defined cystic mass in the right ovary, and ascitis with features suggestive of secondaries over the omentum and peritoneal surface. The serum CA125 was 1255 U/mL (normal range 0-35 U/mL), which was indicative of ovarian malignancy. An exploratory laparotomy was performed. Histopathological examination of organs revealed the presence of granuloma. The patient was advised to undergo antitubercular treatment (ATT) and follow-up every month. After 1 mo of ATT, the CA125 level came down to 42 U/mL, which was near normal. As tuberculosis requires only a conservative management, we suggest that in cases of abdominopelvic mass with or without ascitis, high serum CA125 should always raise a suspicion of tuberculosis and a laparoscopy combined with peritoneal biopsy should be performed to confirm the diagnosis. This will prevent unnecessary laparotomies. Moreover, serum CA125 can be used to monitor the response of disease to antitubercular treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11918456     DOI: 10.1385/MO:18:4:289

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  10 in total

1.  The use of CA-125 in the diagnosis and management of endometriosis.

Authors:  D E Pittaway; J A Fayez
Journal:  Fertil Steril       Date:  1986-11       Impact factor: 7.329

2.  [Immunohistochemical and serologic detection of Ca-125 in patients with peritoneal tuberculosis and ascites].

Authors:  G Ronay; W Jäger; A H Tulusan
Journal:  Geburtshilfe Frauenheilkd       Date:  1989-01       Impact factor: 2.915

3.  Elevated serum CA 125 concentration in patients with tuberculous peritonitis: a case-control study.

Authors:  H Simsek; M C Savas; A Kadayifci; G Tatar
Journal:  Am J Gastroenterol       Date:  1997-07       Impact factor: 10.864

4.  Diagnostic significance of cancer antigen 125, pancreatic oncofetal antigen, and carcinoembryonic antigen in malignant and tuberculous pleural effusions.

Authors:  Y Niwa; K Shimokata
Journal:  Jpn J Clin Oncol       Date:  1986-03       Impact factor: 3.019

5.  Elevated CA 125 in advanced abdominal or pelvic tuberculosis.

Authors:  S S Sheth
Journal:  Int J Gynaecol Obstet       Date:  1996-02       Impact factor: 3.561

6.  Peritoneal tuberculosis with elevated serum CA 125 levels: a case report.

Authors:  T Yoshimura; H Okamura
Journal:  Gynecol Oncol       Date:  1987-11       Impact factor: 5.482

7.  Elevated serum CA 125 secondary to tuberculous peritonitis.

Authors:  S A Candocia; G Y Locker
Journal:  Cancer       Date:  1993-09-15       Impact factor: 6.860

8.  Hormonal regulation of CA125 tumor marker expression in human ovarian carcinoma cells: inhibition by glucocorticoids.

Authors:  B Y Karlan; W Amin; S E Casper; B A Littlefield
Journal:  Cancer Res       Date:  1988-06-15       Impact factor: 12.701

9.  [Immunological assay of the CA-125 value in pleural effusion in various types of pleuritis--its application as a differential diagnostic parameter of tuberculous or carcinomatous pleuritis].

Authors:  Y Mitsutake; Y Hiromatsu; M Saisho; N Tokunaga; Y Ichikawa; M Kaji; K Irie
Journal:  Gan No Rinsho       Date:  1986-05

10.  Elevated serum concentrations of CA-125 in patients with advanced endometriosis.

Authors:  R L Barbieri; J M Niloff; R C Bast; E Scaetzl; R W Kistner; R C Knapp
Journal:  Fertil Steril       Date:  1986-05       Impact factor: 7.329

  10 in total
  17 in total

1.  Diagnostic dilemma of abdominopelvic tuberculosis:a series of 20 cases.

Authors:  Xia Xi; Li Shuang; Wang Dan; Hu Ting; Meng Yu Han; Cao Ying; Mei Quan; ChaoYang Sun; ZhiLan Chen; Feng Cui; Cao Ming; Jian Feng Zhou; Wang Shi Xuan; Yun Ping Lu; Ding Ma
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-09       Impact factor: 4.553

2.  Role of ascites adenosine deaminase in differentiating between tuberculous peritonitis and peritoneal carcinomatosis.

Authors:  Seung Joo Kang; Ji Won Kim; Jee Hyun Baek; Se Hyung Kim; Byeong Gwan Kim; Kook Lae Lee; Ji Bong Jeong; Yong Jin Jung; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

Review 3.  Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature.

Authors:  Ali Uzunkoy; Muge Harma; Mehmet Harma
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

4.  Two cases of tuberculous peritonitis with liver cirrhosis complicated by refractory ascites.

Authors:  Yuu Shimozuma; Takayoshi Ito; Shigeaki Ishii; Momoko Inokuchi; Manabu Uchikoshi; Miyuki Oyama; Kazumasa Hiroishi; Michio Imawari
Journal:  Clin J Gastroenterol       Date:  2009-05-13

5.  Peripancreatic tuberculosis mimicking pancreatic neoplasia.

Authors:  Eric S Weiss; Walter M Klein; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

6.  Female genital tuberculosis presented with primary infertility and persistent CA-125 elevation: A case report.

Authors:  Qian Feng; Xiaoxia Hu; Jing Zhao; Jingyao Huang; Liling Liu
Journal:  Ann Med Surg (Lond)       Date:  2022-05-03

7.  Diagnosis of abdominal tuberculosis.

Authors:  Michelle Petrou; Vassilis Vassiliou
Journal:  J R Soc Med       Date:  2004-03       Impact factor: 18.000

8.  Familial tuberculosis mimicking advanced ovarian cancer.

Authors:  Fakhrolmolouk Yassaee; Farah Farzaneh
Journal:  Infect Dis Obstet Gynecol       Date:  2009-12-21

9.  Clinical significance of serum CA-125 in Korean females with ascites.

Authors:  So Young Bae; Jun Haeng Lee; Jun Young Park; Da-min Kim; Byung-Hoon Min; Poong-Lyul Rhee; Jae J Kim
Journal:  Yonsei Med J       Date:  2013-09       Impact factor: 2.759

10.  Female genital tract tuberculosis presenting as ovarian cancer.

Authors:  Malihe Hasanzadeh; Hamid Reza Naderi; Azamossadat Hoseine Hoshyar; Shima Shabane; Soodabeh Shahidsales
Journal:  J Res Med Sci       Date:  2014-02       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.